Interesting article out of Jian Zuo's lab at St. Jude Children's Research Hospital. They have found a drug called kenpaullone which seems to protect against cisplatin and some noise induced hearing loss. It's a member of a broader class of drugs (CDK2 inhibitors) that seem to have good properties. Time will tell if a statement like "... our discovery of CDK2 inhibitors that act as otoprotectants will probably transform the clinical prevention and treatment of cisplatin ototoxicity and noise-induced hearing loss in patients." will hold up over time. The paper is here:
http://jem.rupress.org/content/early/2018/03/06/jem.20172246 (I don't know much about the Journal of Experimental Medicine. It seems to be more of an immunology journal so it seems like a bit of an odd place to publish something like this.) and a press release is here
https://www.stjude.org/media-resour...on-possible-drug-to-prevent-hearing-loss.html St. Jude seems to be interested in licensing the development of the drug for hearing:
https://www.stjude.org/research/sha...ng-loss-using-cdk2-inhibitors-sj-14-0028.html
Finally, 1) this is a middle ear injection and 2) this is preclinical work in mice and zebrafish so there is no timeline for trials/availability/etc.